The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patients

The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patients

Abstract Aims Ivabradine has been used in patients who have chronic heart failure (HF) with reduced ejection fraction (HFrEF) and concomitant sinus heart rate ≥70 bpm. This administration for acute HFrEF remains a concern. This study used a real‐world multicentre database to investigate the effects...

Full description

Bibliographic Details
Main Authors: Chia‐Te Liao, Jin‐Long Huang, Huai‐Wen Liang, Fa‐Po Chung, Ying‐Hsiang Lee, Po‐Lin Lin, Wei‐Ru Chiou, Wen‐Yu Lin, Chien‐Yi Hsu, Hung‐Yu Chang
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:ESC Heart Failure
Subjects:
Heart failure
Hospitalization
Ivabradine
Mortality
Real‐world
Online Access:https://doi.org/10.1002/ehf2.13536

Internet

https://doi.org/10.1002/ehf2.13536

Similar Items